Zeo ScientifiX (ZEOX) 10-Q2022 Q1 Quarterly report

Filed: 16 Mar 22, 4:06pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. senior Bad

New words: AJB, annum, arise, automated, awaiting, billed, blood, Bloomberg, brokerage, buildout, called, commitment, compensatory, daily, Darbie, dealer, Deceptive, delivered, diligence, eighteen, ELOC, expressly, fee, fraction, fraudulent, Group, harm, hearing, induced, installed, launched, launching, leasehold, listed, Litigation, loan, matter, motion, nanoparticle, national, ordinary, OTC, penalty, peripheral, platform, PPX, PPXTM, private, proceed, promissory, Pure, quotation, raw, registered, regularly, reliance, repayment, representing, repurchase, reserved, scheduled, site, SPA, store, succeed, system, tier, timetable, twelve, twenty, underlying, unexchanged, unissued, unsold, VWAP

Removed: accrue, adjusting, adjustment, advice, advisory, agree, agreeing, amend, annually, appeal, athlete, automatic, automatically, averaging, blank, bringing, celebrity, check, clause, comfort, commencing, comply, confidentiality, consisted, consultant, coordinating, created, critical, death, debenture, desire, detailed, direction, director, disability, earlier, earned, effectuate, eligible, ending, enter, equivalency, establishing, exceed, exercisable, expertise, expiration, failure, favor, FINRA, fringe, functional, Global, guaranty, hereunder, holder, Immune, individually, intellectual, intention, intentional, introduction, maximum, met, mission, modify, mutually, newly, notice, order, OrganicellTM, override, oversight, participate, participated, partly, percent, personal, planned, President, primary, provision, ranging, referred, refusal, relating, release, renewal, Reorganization, Republic, resource, responsible, retroactive, retroactively, Revised, run, Science, select, serve, settlement, similarly, situated, standard, successive, terminate, termination, thereof, turnkey, uncertainty, unregistered, unreimbursed, updated, vesting, Vice, voting, weekly, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ZEOX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Organicell Regenerative Medicine, Inc. on Form 10-Q for the quarter ended January 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Albert Mitrani, Chief Executive Officer and President of Organicell Regenerative Medicine, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Biotech Products Services and Research, Inc.

Date: March 16, 2022	/s/ ALBERT MITRANI
	Albert Mitrani
	Chief Executive Officer
	(Principal Executive Officer)